Biotech company Enzium is first company to open HQ at USciences - Technical.ly Philly

Business

Nov. 11, 2013 10:00 am

Biotech company Enzium is first company to open HQ at USciences

Enzium came to University of the Sciences in part because Enzium cofounder Peter Berget is now the chair of the biology department at the college. Berget, who joined University of the Sciences in August of 2011, developed the technology behind Enzium while he was a professor at Carnegie Mellon.
Photo from Campus Philly.

Photo from Campus Philly.

The University of the Sciences welcomed its first startup last month.

Enzium, a biotech company previously located in Pittsburgh, will be headquartered at the college for at least one year, according to a release. It will be the first time that an outside startup opens an office at the school, the release said.

Enzium came to University of the Sciences in part because Enzium cofounder Peter Berget is now the chair of the biology department at the college. Berget, who joined University of the Sciences in August of 2011, developed the technology behind Enzium while he was a professor at Carnegie Mellon.

Led by Crystal Falco, Enzium manufactures kits that detect enzyme activity. The company is backed by life sciences investor BioAdvance.

-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

Success in life sciences begets more success: What Philly leaders say about the industry’s growth

Philadelphia is having its best year for VC deals since 2000

SPONSORED

Philly

How ShopRunner’s mentorship program is pushing its employees to think beyond their fields

Chesterbrook, PA

Deacom

Entry Level Software Developer

Apply Now

King of Prussia, PA

Deacom

Deacom

Apply Now

Philadelphia, PA

Macquarie

Technical Lead – Asset Management Software

Apply Now

Exton cell and gene therapy company Fibrocell will be acquired for $63.3M

Carisma Therapeutics raised nearly $60M in Series A funding. Now what?

A Center City biotech company is using an algorithm to help patients with memory loss

SPONSORED

Philly

How Relay is helping enterprise clients get proactive about customer engagement

Philadelphia, PA

Macquarie

Global Data Technology Senior Manager

Apply Now

Philadelphia, Pennsylvania

Macquarie

Data Modeler

Apply Now

Horsham

Penn Mutual Life Insurance Co

Product Systems Specialist

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!